TP53 and acute myeloid leukemia: Recent updates to the European LeukemiaNet (ELN) guidelines for AML stratification include RUNX1, TP53, and ASXL15, and more recently published schemes incorporate mutational status in 25 genes and propose 14 separate disease subtypes, although this has not been clinically incorporated6.